TD Asset Management
LJPC

TD Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

TD Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,800
Closed -$348K – 1411
2017
Q4 		$348K Sell
10,800
-2,100
-16% -$68.6K ﹤0.01% 1245
2017
Q3 		$449K Buy
+12,900
New +$415K ﹤0.01% 1180

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

TD Asset Management's LJPC Position: Q1 2018 in Review

TD Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2018, closing a stake of 10,800 shares — an estimated $348K sold.

TD Asset Management first reported a position in LJPC in Q3 2017 and held it in 2 quarters. The position peaked at $449K in Q3 2017. 100 funds tracked by Wall St. Rank hold LJPC as of Q1 2018.

  • TD Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2018 after selling out during the quarter.
  • TD Asset Management sold 10,800 La Jolla Pharmaceutical Company shares in Q1 2018, an estimated $348K.
  • TD Asset Management first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 2 quarters.
  • TD Asset Management's La Jolla Pharmaceutical Company position peaked at $449K in Q3 2017.
  • 100 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2018.

Based on TD Asset Management's 13F filing for Q1 2018, filed 11 May 2018.